Speaker Profile

Ph.D., Managing Executive, Personalized Science, LLC

Biography
Dr. Eric Lai is Managing Executive at Personalized Science, LLC and currently a team lead with the NIH COVID-19 Rapid Acceleration of Diagnostics (RADx) Initiative. For almost 30 years, Dr. Lai has focused his efforts in the clinical application of Pharmacogenomics in drug development and drug safety, from discovery to bedside. In 2002, Dr. Lai discovered the association of HLA5701 to the Abacavir hypersensitivity reaction. The Abacavir HLA5701 discovery significantly improved the benefit-risk relationship by identifying patients at high risk for a serious drug adverse reaction and is frequently quoted in FDA guidance as one of the most important demonstrations of genomic medicine.


×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by AUG. 1ST

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required